Literature DB >> 12449551

2001 Canadian hypertension recommendations. What has changed?

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12449551      PMCID： PMC2213948     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  14 in total

Review 1.  Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology.

Authors:  S M Grundy; R Pasternak; P Greenland; S Smith; V Fuster
Journal:  Circulation       Date:  1999-09-28       Impact factor: 29.690

2.  Updated New Zealand cardiovascular disease risk-benefit prediction guide.

Authors:  R Jackson
Journal:  BMJ       Date:  2000-03-11

3.  Blood pressure measuring devices: recommendations of the European Society of Hypertension.

Authors:  E O'Brien; B Waeber; G Parati; J Staessen; M G Myers
Journal:  BMJ       Date:  2001-03-03

4.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

Review 5.  A novel process for updating recommendations for managing hypertension: rationale and methods.

Authors:  K B Zarnke; N R Campbell; F A McAlister; M Levine
Journal:  Can J Cardiol       Date:  2000-09       Impact factor: 5.223

6.  1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension.

Authors:  R D Feldman; N Campbell; P Larochelle; P Bolli; E D Burgess; S G Carruthers; J S Floras; R B Haynes; G Honos; F H Leenen; L A Leiter; A G Logan; M G Myers; J D Spence; K B Zarnke
Journal:  CMAJ       Date:  1999       Impact factor: 8.262

7.  The 2000 Canadian recommendations for the management of hypertension: Part one--therapy.

Authors:  F A McAlister; M Levine; K B Zarnke; N Campbell; R Lewanczuk; F Leenen; S Rabkin; J M Wright; J Stone; R D Feldman; M Lebel; G Honos; G Fodor; E Burgess; S Tobe; P Hamet; R Herman; J Irvine; B Culleton; R Petrella; R Touyz
Journal:  Can J Cardiol       Date:  2001-05       Impact factor: 5.223

Review 8.  The 2000 Canadian recommendations for the management of hypertension: part two--diagnosis and assessment of people with high blood pressure.

Authors:  K B Zarnke; M Levine; F A McAlister; N R Campbell; M G Myers; D W McKay; P Bolli; G Honos; M Lebel; K Mann; T W Wilson; C Abbott; S Tobe; E Burgess; S Rabkin
Journal:  Can J Cardiol       Date:  2001-12       Impact factor: 5.223

9.  Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.

Authors: 
Journal:  Lancet       Date:  2001-09-29       Impact factor: 79.321

10.  The 2001 Canadian recommendations for the management of hypertension: Part one--Assessment for diagnosis, cardiovascular risk, causes and lifestyle modification.

Authors:  Kelly B Zarnke; Finlay A McAlister; Norman R C Campbell; Mitchell Levine; Ernesto L Schiffrin; Steven Grover; Donald W McKay; Martin G Myers; Thomas W Wilson; Simon W Rabkin; Ross D Feldman; Ellen Burgess; Peter Bolli; George Honos; Marcel Lebel; Karen Mann; Carl Abbott; Sheldon Tobe; Robert Petrella; Rhian M Touyz
Journal:  Can J Cardiol       Date:  2002-06       Impact factor: 5.223
View more
  1 in total

1.  Polytherapy with two or more antihypertensive drugs to lower blood pressure in elderly Ontarians. Room for improvement.

Authors:  Norman R C Campbell; Finlay A McAlister; Minh Duong-Hua; Karen Tu
Journal:  Can J Cardiol       Date:  2007-08       Impact factor: 5.223
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.